494 related articles for article (PubMed ID: 17553456)
1. Amyloid beta ion channel: 3D structure and relevance to amyloid channel paradigm.
Lal R; Lin H; Quist AP
Biochim Biophys Acta; 2007 Aug; 1768(8):1966-75. PubMed ID: 17553456
[TBL] [Abstract][Full Text] [Related]
2. Abeta ion channels. Prospects for treating Alzheimer's disease with Abeta channel blockers.
Arispe N; Diaz JC; Simakova O
Biochim Biophys Acta; 2007 Aug; 1768(8):1952-65. PubMed ID: 17490607
[TBL] [Abstract][Full Text] [Related]
3. Atomic force microscopy and MD simulations reveal pore-like structures of all-D-enantiomer of Alzheimer's β-amyloid peptide: relevance to the ion channel mechanism of AD pathology.
Connelly L; Jang H; Arce FT; Capone R; Kotler SA; Ramachandran S; Kagan BL; Nussinov R; Lal R
J Phys Chem B; 2012 Feb; 116(5):1728-35. PubMed ID: 22217000
[TBL] [Abstract][Full Text] [Related]
4. Amyloid β Ion Channels in a Membrane Comprising Brain Total Lipid Extracts.
Lee J; Kim YH; T Arce F; Gillman AL; Jang H; Kagan BL; Nussinov R; Yang J; Lal R
ACS Chem Neurosci; 2017 Jun; 8(6):1348-1357. PubMed ID: 28135799
[TBL] [Abstract][Full Text] [Related]
5. Ion Channel Formation by Amyloid-β42 Oligomers but Not Amyloid-β40 in Cellular Membranes.
Bode DC; Baker MD; Viles JH
J Biol Chem; 2017 Jan; 292(4):1404-1413. PubMed ID: 27927987
[TBL] [Abstract][Full Text] [Related]
6. New structures help the modeling of toxic amyloidbeta ion channels.
Jang H; Zheng J; Lal R; Nussinov R
Trends Biochem Sci; 2008 Feb; 33(2):91-100. PubMed ID: 18182298
[TBL] [Abstract][Full Text] [Related]
7. Disordered amyloidogenic peptides may insert into the membrane and assemble into common cyclic structural motifs.
Jang H; Arce FT; Ramachandran S; Kagan BL; Lal R; Nussinov R
Chem Soc Rev; 2014 Oct; 43(19):6750-64. PubMed ID: 24566672
[TBL] [Abstract][Full Text] [Related]
8. The ongoing search for small molecules to study metal-associated amyloid-β species in Alzheimer's disease.
Savelieff MG; DeToma AS; Derrick JS; Lim MH
Acc Chem Res; 2014 Aug; 47(8):2475-82. PubMed ID: 25080056
[TBL] [Abstract][Full Text] [Related]
9. Alzheimer Aβ peptide interactions with lipid membranes: fibrils, oligomers and polymorphic amyloid channels.
Tofoleanu F; Buchete NV
Prion; 2012; 6(4):339-45. PubMed ID: 22874669
[TBL] [Abstract][Full Text] [Related]
10. Untangling amyloid-β, tau, and metals in Alzheimer's disease.
Savelieff MG; Lee S; Liu Y; Lim MH
ACS Chem Biol; 2013 May; 8(5):856-65. PubMed ID: 23506614
[TBL] [Abstract][Full Text] [Related]
11. Alzheimer's disease.
De-Paula VJ; Radanovic M; Diniz BS; Forlenza OV
Subcell Biochem; 2012; 65():329-52. PubMed ID: 23225010
[TBL] [Abstract][Full Text] [Related]
12. Atomic force microscopy to study molecular mechanisms of amyloid fibril formation and toxicity in Alzheimer's disease.
Drolle E; Hane F; Lee B; Leonenko Z
Drug Metab Rev; 2014 May; 46(2):207-23. PubMed ID: 24495298
[TBL] [Abstract][Full Text] [Related]
13. How do membranes initiate Alzheimer's Disease? Formation of toxic amyloid fibrils by the amyloid β-protein on ganglioside clusters.
Matsuzaki K
Acc Chem Res; 2014 Aug; 47(8):2397-404. PubMed ID: 25029558
[TBL] [Abstract][Full Text] [Related]
14. Truncated beta-amyloid peptide channels provide an alternative mechanism for Alzheimer's Disease and Down syndrome.
Jang H; Arce FT; Ramachandran S; Capone R; Azimova R; Kagan BL; Nussinov R; Lal R
Proc Natl Acad Sci U S A; 2010 Apr; 107(14):6538-43. PubMed ID: 20308552
[TBL] [Abstract][Full Text] [Related]
15. The monomers, oligomers, and fibrils of amyloid-β inhibit the activity of mitoBK
Kravenska Y; Nieznanska H; Nieznanski K; Lukyanetz E; Szewczyk A; Koprowski P
Biochim Biophys Acta Biomembr; 2020 Sep; 1862(9):183337. PubMed ID: 32380169
[TBL] [Abstract][Full Text] [Related]
16. Models of beta-amyloid ion channels in the membrane suggest that channel formation in the bilayer is a dynamic process.
Jang H; Zheng J; Nussinov R
Biophys J; 2007 Sep; 93(6):1938-49. PubMed ID: 17526580
[TBL] [Abstract][Full Text] [Related]
17. Amyloid β oligomers in Alzheimer's disease pathogenesis, treatment, and diagnosis.
Viola KL; Klein WL
Acta Neuropathol; 2015 Feb; 129(2):183-206. PubMed ID: 25604547
[TBL] [Abstract][Full Text] [Related]
18. Physicochemical characteristics of soluble oligomeric Abeta and their pathologic role in Alzheimer's disease.
Watson D; Castaño E; Kokjohn TA; Kuo YM; Lyubchenko Y; Pinsky D; Connolly ES; Esh C; Luehrs DC; Stine WB; Rowse LM; Emmerling MR; Roher AE
Neurol Res; 2005 Dec; 27(8):869-81. PubMed ID: 16354549
[TBL] [Abstract][Full Text] [Related]
19. Interaction of Alzheimer's β-amyloid peptides with cholesterol: mechanistic insights into amyloid pore formation.
Di Scala C; Chahinian H; Yahi N; Garmy N; Fantini J
Biochemistry; 2014 Jul; 53(28):4489-502. PubMed ID: 25000142
[TBL] [Abstract][Full Text] [Related]
20. Amyloid beta-peptide interactions with neuronal and glial cell plasma membrane: binding sites and implications for Alzheimer's disease.
Verdier Y; Zarándi M; Penke B
J Pept Sci; 2004 May; 10(5):229-48. PubMed ID: 15160835
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
